Cloud-clone
SKU:RPE189Mu01
Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
Couldn't load pickup availability
Prokaryotic expression
Product No.
RPE189Mu01
Organism Species
Mus musculus (Mouse).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Cytoplasm
Predicted Molecular Mass
87.3kDa
Accurate Molecular Mass
87.3kDa(Analysis of differences refer to the manual)
Residues & Tags
Ser156~Gln694 with N-terminal His and GST Tag
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Traits
Freeze-dried powder
Purity
> 97%
Isoelectric Point
7.51
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Biological Trace Element Research | Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers pubmed:28409410 |
| BASIC RESEARCH IN CARDIOLOGY | Autocrine effects of PCSK9 on cardiomyocytes Pubmed: 33169229 |
| J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans 33407555 |
| Metabolism | MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice 33775647 |
| Eur Rev Med Pharmacol Sci | Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders 34533801 |
| Clin Exp Hypertens | Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease Pubmed:35502687 |
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
| RPE189Mu02 | Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPE189Mu01 | Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAE189Mu01 | Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | WB; IHC; ICC; IP. |
| PAE189Mu02 | Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | WB; IHC; ICC; IP. |
| SEE189Mu | ELISA Kit for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LME189Mu | Magnetic Luminex Assay Kit for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
